Sabby Management’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-67,000
| Closed | -$328K | – | 123 |
|
|
2018
Q1 | $328K | Sell |
67,000
-262,400
| -80% | -$1.28M | 0.04% | 60 |
|
|
2017
Q4 | $931K | Buy |
329,400
+21,800
| +7% | +$61.6K | 0.08% | 23 |
|
|
2017
Q3 | $907K | Sell |
307,600
-3,208
| -1% | -$9.46K | 0.06% | 26 |
|
|
2017
Q2 | $979K | Buy |
310,808
+14,330
| +5% | +$45.1K | 0.06% | 35 |
|
|
2017
Q1 | $1.19M | Buy |
+296,478
| New | +$1.19M | 0.06% | 39 |
|